It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The pathogenesis of thyroid dysgenesis (TD) is not well understood. Here, using a combination of single-cell RNA and spatial transcriptome sequencing, we identify a subgroup of NF-κB-activated thyrocytes located at the center of thyroid tissues in postnatal mice, which maintained a partially mesenchymal phenotype. These cells actively protruded out of the thyroid primordium and generated new follicles in zebrafish embryos through continuous tracing. Suppressing NF-κB signaling affected thyrocyte migration and follicle formation, leading to a TD-like phenotype in both mice and zebrafish. Interestingly, during thyroid folliculogenesis, myeloid cells played a crucial role in promoting thyrocyte migration by maintaining close contact and secreting TNF-α. We found that cebpa mutant zebrafish, in which all myeloid cells were depleted, exhibited thyrocyte migration defects. Taken together, our results suggest that myeloid-derived TNF-α-induced NF-κB activation plays a critical role in promoting the migration of vertebrate thyrocytes for follicle generation.
The mechanism underlying thyroid follicle formation is not well understood. Here, the authors show that a subgroup of NF-κB-activated thyrocytes, through interactions with myeloid cells, exhibit increased migration capacity to generate new follicles.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Shanghai Jiao Tong University School of Medicine, Department of Molecular Diagnostics & Endocrinology, Shanghai Ninth People’s Hospital, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293)
2 Shanghai Medical College, Fudan University, Department of Oncology, Shanghai, China (GRID:grid.11841.3d) (ISNI:0000 0004 0619 8943)
3 Shanghai Jiao Tong University School of Medicine, Department of Urology, Shanghai Ninth People’s Hospital, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293)
4 Maternal and Child Health Institute of Bozhou, Department of Endocrinology, Bozhou, China (GRID:grid.16821.3c)
5 Fujian Medical University, Department of Laboratory Medicine, Fujian Children’s Hospital, Fuzhou, China (GRID:grid.256112.3) (ISNI:0000 0004 1797 9307)
6 The Linyi People’s Hospital, Department of Endocrinology, Linyi, China (GRID:grid.415946.b) (ISNI:0000 0004 7434 8069)
7 The Central Hospital of Xuzhou Affiliated to Xuzhou Medical College, Department of Endocrinology, Xuzhou, China (GRID:grid.417303.2) (ISNI:0000 0000 9927 0537)
8 Boston Children’s Hospital and Harvard Stem Cell Institute, Stem Cell Program, Boston, USA (GRID:grid.511171.2); Boston Children’s Hospital and Dana Farber Cancer Institute, Division of Hematology/Oncology, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438)